Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

Sex - we can chemically get it up and now last longer?

August 2, 2009

Sciele Pharma And Plethora Solutions Announce Positive Results Of Final Phase III Pivotal Trial For PSD502 For Premature Ejaculation | www.medicalnewstoday.com

?? breakthrough

A missed opportunity - or is it?

June 30, 2009

FDA throws up roadblock for Takeda's diabetes drug | www.fiercebiotech.com

Plusses and minuses of not getting in the market now.

Remember the frying pan?

December 16, 2008

Scientists back brain drugs for healthy people | www.washingtonpost.com

This is an abuse of medication - what we don't need

Asthma - will this help??

December 15, 2008

FDA: Long-Acting Asthma Drugs Increase Asthma Risks | online.wsj.com

Ruling not unreasonable, but may cause confusion to patients.

A rough in the diamond

August 27, 2008

FDA Alert: Hemorrhagic or Necrotizing Pancreatitis in Patients Taking Byetta | www.fda.gov

If truly an association, this will alter the use of this drug.

Onglyza - ? engagement ring for Astra Zeneca and Bristol-Myers Squibb

July 28, 2008

AstraZeneca and Bristol-Myers Squibb Submit New Drug Application in the United States and Marketing Authorisation Application in Europe for ONGLYZA™ (Saxagliptin) for the Treatment of Type 2 Diabetes | www.astrazeneca.com

DDP4 inhibitor class fairly new.  Another arrow in the theraputic quiver

Fractures from Fosamax???

July 18, 2008

Drugs to Build Bones May Weaken Them | www.nytimes.com

Patients may ask about this.  Haven't heard anyone yet.

Symbicort will give a lift to the little ones

June 6, 2008

AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six | www.pipelinereview.com

Good drug with rapid onset.  ? if will create some confusion with adult dosing    

Blue Cross Mass. New Payment Plan - A rose by any other name would smell as ?sweet

January 23, 2008

New therapy for old woes, Blue Cross measure aims to slow runaway costs, improve quality of healthcare | www.boston.com

A new idea - I don't think so Trust Blue Cross??????

Lyrica and fibromyalgia - I hope it works

June 25, 2007

Pfizer’s Lyrica Receives FDA Approval for Fibromyalgia | home.businesswire.com

Something actually indicated for this disease.

INTUNIV - another arrow in the quiver is welcome

June 25, 2007

Shire Receives Approvable Letter from FDA for INTUNIV(TM) (guanfacine) Extended Release, a Nonstimulant for the Treatment of ADHD | www.pipelinereview.com

Alternative drug to use.  Lower abuse potential  Lower stigma

Actonel 75 - the glass 1/2 full?

June 25, 2007

The U.S. Food and Drug Administration Approves New Actonel Dose to Treat and Prevent Postmenopausal Osteoporosis | phx.corporate-ir.net

Compliance issues  ? side effects

Free at last!

November 20, 2006

Bayer and Ortho-McNeil, Inc. Outline Phase III Study Program of Oral Factor Xa Inhibitor Rivaroxaban in Chronic Indications | www.pipelinereview.com

An oral anticoagulant that does not require monitoring.

Food for thought

November 20, 2006

Shire Announces Results Of A Meta-Analysis Comparing Stimulant Medications To Non-Stimulant Medications In Treating ADHD In Patients Aged 8 To 15 | www.medicalnewstoday.com

There is a difference between medications. Need to ask what type of patient is being treated.

 

Oral Insulin - ? if ready yet

November 10, 2006

Emisphere Reports Additional Clinical Data From Phase 2 Oral Insulin Trial | www.medicalnewstoday.com

Patients on highest dose - 10 mg 4x/day had best drop. Decreases were 0.1-0.22% depending on the A1C. 2 of 10 had a significant drop to an A1C of 7 or lower.

Page : 11 to 15 of 15

Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

This author consults with leading institutions through GLG